Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-02 5:16 pm Purchase |
2025-03-31 | 13D | Mustang Bio, Inc. MBIO |
Fortress Biotech Inc. FBIO |
199,191 7.900% |
199,191 (New Position) |
Filing History |
| 2025-04-02 5:00 pm Purchase |
2025-03-31 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
328,746 10.300% |
33,724 (+11.43%) |
Filing History |
| 2025-03-11 4:29 pm Purchase |
2025-03-09 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
6,922,249 11.200% |
18,500 (+0.27%) |
Filing History |
| 2025-01-03 6:26 pm Purchase |
2024-12-31 | 13D | Mustang Bio, Inc. MBIO |
Fortress Biotech Inc. FBIO |
6,569,450 12.400% |
4,049,793 (+160.73%) |
Filing History |
| 2025-01-03 6:26 pm Purchase |
2024-12-31 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
6,903,749 13.500% |
2,468,215 (+55.65%) |
Filing History |
| 2025-01-03 5:50 pm Purchase |
2024-12-31 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
295,022 13.800% |
114,597 (+63.52%) |
Filing History |
| 2024-11-15 4:05 pm Purchase |
2024-11-13 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
180,425 8.900% |
180,425 (New Position) |
Filing History |
| 2024-10-25 10:15 am Purchase |
2024-09-30 | 13G | Fortress Biotech, Inc. FBIO |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,734,854 9.000% |
2,734,854 (New Position) |
Filing History |
| 2024-10-01 4:15 pm Purchase |
2024-09-27 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
4,435,534 9.800% |
146,341 (+3.41%) |
Filing History |
| 2024-09-25 4:45 pm Purchase |
2024-09-23 | 13D | Fortress Biotech, Inc. FBIO |
ROSENWALD LINDSAY A MD | 5,224,779 18.400% |
2,410,874 (+85.68%) |
Filing History |
| 2024-06-28 4:26 pm Purchase |
2024-06-27 | 13D | Mustang Bio, Inc. MBIO |
Fortress Biotech Inc. FBIO |
2,519,657 7.400% |
2,519,657 (New Position) |
Filing History |
| 2024-05-17 5:13 pm Purchase |
2024-05-16 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
4,289,193 11.200% |
1,492,915 (+53.39%) |
Filing History |
| 2024-04-17 4:05 pm Purchase |
2024-04-16 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
47,521 8.000% |
33,533 (+239.74%) |
Filing History |
| 2024-03-22 6:24 pm Purchase |
2024-03-20 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,796,278 7.500% |
352,039 (+14.40%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management, LLC | 372,562 4.200% |
-158,642 (-29.86%) |
Filing History |
| 2024-01-03 4:41 pm Purchase |
2024-01-01 | 13D | Fortress Biotech, Inc. FBIO |
ROSENWALD LINDSAY A MD | 2,813,905 15.300% |
216,465 (+8.33%) |
Filing History |
| 2023-11-21 4:09 pm Purchase |
2023-11-14 | 13D | Fortress Biotech, Inc. FBIO |
WEISS MICHAEL S | 1,130,520 7.600% |
1,130,520 (New Position) |
Filing History |
| 2023-11-21 4:08 pm Purchase |
2023-11-14 | 13D | Fortress Biotech, Inc. FBIO |
ROSENWALD LINDSAY A MD | 2,597,440 17.500% |
2,597,440 (New Position) |
Filing History |
| 2023-09-26 4:16 pm Purchase |
2023-09-25 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,444,239 11.300% |
80,906 (+3.42%) |
Filing History |
| 2023-09-18 5:08 pm Purchase |
2023-09-08 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
13,987 12.100% |
13,987 (New Position) |
Filing History |